Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Reproductive coercion and domestic abuse

Essential points for quick revision.

Saved on this device
!
Immediate danger requires a safe response

Life-threatening injury, strangulation, sexual assault, suicidal intent, escalating threats, stalking, weapon access, forced confinement or a child in immediate danger requires emergency and safeguarding action.

Action: Use emergency services and the applicable national safeguarding pathway, avoid alerting the alleged perpetrator, and involve a specialist domestic-abuse advocate when safe.

Synopsis

Recognise reproductive control within domestic abuse, ask safely and privately, address urgent injury and pregnancy or infection needs, protect confidential communications, and coordinate survivor-led safeguarding and advocacy.

  • Ask about abuse and reproductive control alone, in a private setting, using a professional interpreter and a simple empathetic explanation for the questions.
  • Reproductive coercion includes contraception sabotage, forced sex, pressure about pregnancy outcome, interference with fertility care and control of appointments or medicines.
  • Respond with belief and validation, assess immediate danger and medical needs, and ask what the patient wants help with today.

Key red flags

Strangulation, threats to kill, weapon access, stalking, escalating violence or separation can signal high and imminent homicide risk.

Contraceptive sabotage, forced unprotected sex, prevention of contraception, forced pregnancy or pressure to end a pregnancy are forms of reproductive coercion.

A partner who answers every question, refuses to leave, controls transport, medication, money or the telephone prevents confidential assessment.

Pregnancy can increase contact with healthcare and may coincide with the onset or escalation of domestic abuse.

Children who see, hear or experience the effects of domestic abuse have safeguarding needs even when they are not physically assaulted.

Portal messages, letters, prescriptions, pharmacy records and phone calls can expose care to a controlling partner unless communication safety is checked.

High-risk escalation

Strangulation, threats to kill, stalking, weapon access or violence around separation requires urgent specialist risk response.

Child impact

Children exposed to the effects of domestic abuse require safeguarding consideration even without a disclosed physical assault.

Reasoning priorities

01
Private domestic-abuse and reproductive-control enquiry

Identify fear, coercion, sexual violence and interference with contraception, fertility or pregnancy decisions.

A disclosure guides safety and care; non-disclosure does not exclude abuse and should not trigger confrontation.

Worked reasoning

Worked caseRespond without removing autonomy

A patient privately discloses that a partner destroys contraception and threatens violence if pregnancy is prevented.

  1. Validate the disclosure, assess injury, strangulation, immediate danger, sexual assault, pregnancy, suicidality and children at risk.
  2. Ask what help is wanted now and offer time-sensitive pregnancy, contraception, STI and HIV care without requiring police reporting or separation.
  3. With consent, contact a specialist domestic-abuse advocate and build a safety plan covering transport, medicines, documents, children and digital surveillance.
  4. Agree a safe communication method, document facts and disclosure decisions, and arrange named clinical and safeguarding follow-up.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 13 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 13 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom